Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

Clinical trial NCT05738850 · COMPLETED

Trial details

NCT number: NCT05738850
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Generalized Anxiety Disorder (GAD)Healthy Participants

Start date: 2023-02-15
Primary completion: 2024-05-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.